# A Study of Psilocybin for PTSD

> **NCT06407635** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Johns Hopkins University** · enrollment: 20 (estimated)

## Conditions studied

- Post Traumatic Stress Disorder

## Interventions

- **DRUG:** Psilocybin
- **OTHER:** Trauma-focused psychotherapy
- **OTHER:** Standard psychological support

## Key facts

- **NCT ID:** NCT06407635
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-06-07
- **Primary completion:** 2026-05
- **Final completion:** 2027-05
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-10-31

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06407635

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06407635, "A Study of Psilocybin for PTSD". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06407635. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*